Skip to main content
. 2021 Jun 3;9(6):640. doi: 10.3390/biomedicines9060640

Figure 1.

Figure 1

Schematic process of EGFRvIII-BsAb synthesis by the BAPTS platform. In this method, under 4–25 °C and reduced conditions, fragment A and fragment B were fused into a complete bispecific antibody, and the intein was dropped.